Srihari S. Naidu, MD, is an interventional cardiology expert in both the minimally-invasive treatments of heart disease and hypertrophic cardiomyopathy, the most common cause of sudden death in athletes and a cause of heart failure at all ages.  He is Board Certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology and is a Full Professor of Medicine at New York Medical College.

Prior to joining Westchester Medical Center in 2016, Dr. Naidu was an Assistant Professor of Medicine at New York Presbyterian Hospital - Weill Cornell Medical Center and then Associate Professor of Medicine at SUNY Stony Brook. Dr. Naidu developed the Hypertrophic Cardiomyopathy Center at Cornell, performing their first series of alcohol septal ablations, and then grew it to over 800 patients and over 130 alcohol ablations while making it a Center of Excellence at Winthrop.  Dr. Naidu trained in Internal Medicine at Cornell, and General and Interventional Cardiology at the University of Pennsylvania.  

A graduate of the 8-year Program in Liberal Medical Education at Brown University, Dr. Naidu is Past President of the Medical School Board of Directors, Reunion Chair of the Class of 1993 and Trustee Emeritus of the Brown University Corporation.

In 2016, Dr. Naidu was recruited to Westchester Medical Center.  He is the Director of the Cardiac Catheterization Laboratories and HCM Center.  The Center has two offices, serving of the largest regions of the country, spanning Upstate NY, Western MA, Western CT, Long Island, the five boroughs of NYC, and parts of Northern and Central NJ, although patients travel to the Center from all reaches of the United States.  The Program received National Center of Excellence designation from the Hypertrophic Cardiomyopathy as one of 30 centers nationwide.

A Fellow of the American College of Cardiology (FACC), American Heart Association (FAHA), and Society for Cardiovascular Angiography and Interventions (FSCAI), Dr. Naidu served on several national committees, including the ACC Interventional Science Council (two term member) and Curriculum Design Committee, and is an Associate Director for TCT.  Dr. Naidu Founded the SCAI Emerging Leader Mentorship (ELM) Program in partnership with ACC and the Cardiovascular Research Foundation (CRF), the interventional leadership pipeline that selects 12 interventional cardiologists every 2 years for national roles.  He is Past Trustee of SCAI and Chair of Development and Industry Relations, and on the Board of Directors of the International Andreas Gruentzig Society (IAGS).

Dr. Naidu has over 100 publications, and lectures throughout the United States.  He is Editor of two textbooks - Hypertrophic Cardiomyopathy, by Springer, now in its 2nd Edition, and Interventional Heart Failure, by Elsevier. In addition, he serves as Invited Speaker for the American College of Cardiology (ACC), American Heart Association (AHA), Transcatheter Cardiovascular Therapeutics (TCT), and Society for Cardiac Angiography and Intervention (SCAI) Scientific Sessions.